Login / Signup
Comparison of Clinical Therapeutic Efficacy between TUPKP and HoLEP for Patients Aged 70 Years and Older with Benign Prostatic Hyperplasia: Retrospective Study.
Jian Wu
Shuhuang Chen
Xiubin Ye
Zheying Ouyang
Renrui Kuang
Published in:
Archivos espanoles de urologia (2024)
HoLEP for BPH therapy is effective and safe with low incidence of postoperative complications.
Keyphrases
</>
benign prostatic hyperplasia
lower urinary tract symptoms
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
physical activity
stem cells
mesenchymal stem cells
middle aged
bone marrow
community dwelling